Tumor SOCS3 methylation status predicts the treatment response to TACE and prognosis in HCC patients

BACKGROUND: Suppressor of cytokine signaling (SOCS) 1 and 3 methylation have been associated with clinical features and outcomes of cancer patients. However, their roles in determining the treatment response to transarterial chemoembolization (TACE) in patients with hepatocellular carcinoma (HCC) re...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncotarget
Hoofdauteurs: Jiang, Bei-Ge, Wang, Neng, Huang, Jian, Yang, Yuan, Sun, Liang-Liang, Pan, Ze-Ya, Zhou, Wei-Ping
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2017
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5438677/
https://ncbi.nlm.nih.gov/pubmed/28404963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16157
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items